YOLFTbeta
Galectin Therapeutics Inc

Galectin Therapeutics Inc

GALT · NASDAQ · Healthcare / Biotechnology

3.05USD-0.09 (-2.87%)

Price History

Full chart

Market Stats

Previous Close3.14
Open3.16
Day Range2.93 – 3.31
52-Week Range2.03 – 7.13
Volume181.60K
Market Cap393.31M
P/E (TTM)0.00
Forward P/E4.54
EPS-0.43
Dividend Yield0.00%
Beta0.39
50-Day Avg3.72
200-Day Avg3.33

About

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Joel Lewis CPA
  • Employees9
  • Headquarters4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071, USA
  • Websitehttps://galectintherapeutics.com

Leadership

  • Mr. Joel Lewis CPAPresident & CEO · b. 1970
  • Mr. Jack W. Callicutt CPACFO, Treasurer & Corporate Secretary · b. 1967
  • Dr. Khurram Jamil M.D.Chief Medical Officer · b. 1976
  • Mr. Robert Tritt J.D.General Counsel
  • Mr. Jim Wilkins Ph.D.Head of CMC & Pharmaceutical Development
  • Ms. Beth KnowlesExecutive Assistant & Officer Manager

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----------000000000000000
Cost of Revenue------67.00K64.00K49.00K--00007.00K7.00K1.00K1.00K35.00K36.00K41.00K32.00K33.00K37.00K-
Gross Profit-------7.05M-6.46M-5.33M--0000-7.00K-7.00K-1.00K-1.00K-35.00K-36.00K-41.00K-32.00K-33.00K-37.00K-
Operating Expense------000--10.41M9.90M12.10M15.43M20.07M21.47M16.25M13.60M13.40M23.41M30.14M38.32M38.04M42.40M-
Operating Income-170.00K-2.18M-3.29M-4.94M-7.30M-6.66M-7.05M-6.46M-5.33M-6.09M-4.88M-10.41M-9.90M-12.10M-15.43M-20.08M-21.48M-16.25M-13.60M-13.44M-23.44M-30.18M-38.35M-38.07M-42.43M-20.09M
EBITDA-170.00K-2.02M-3.08M-4.85M-7.10M-6.77M-1.28M-9.02M-3.10M-7.42M-5.62M-10.91M-9.67M-12.08M-15.42M-20.02M-21.47M-16.22M-13.56M-13.17M-23.34M-30.00M-37.71M-38.24M-41.47M-23.45M
Net Income-190.00K-3.97M-3.68M-4.87M-7.18M-6.54M-3.19M-9.43M-3.15M-7.46M-5.63M-10.91M-9.68M-12.09M-15.79M-20.03M-21.44M-16.23M-13.90M-13.29M-23.46M-30.53M-38.78M-41.07M-47.05M-30.84M
R&D100.00K893.46K1.48M1.95M3.04M3.04M3.02M2.05M1.77M1.11M1.07M3.55M4.53M5.69M8.43M13.11M15.32M11.72M6.47M7.47M17.98M23.82M31.74M32.13M36.57M14.29M
Interest Expense00415.42K3.88K001.85M350.00K00000000012.00K336.00K87.00K87.00K489.00K1.03M2.79M5.54M7.33M

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets230.00K1.77M2.28M8.00M11.11M4.96M6.36M1.78M704.00K436.00K6.30M6.61M9.56M10.71M29.68M26.41M15.79M4.16M9.01M48.47M29.60M41.83M21.29M28.20M17.50M19.53M
Total Liabilities180.00K550.70K666.79K377.91K1.00M1.38M6.38M4.71M1.17M4.90M7.99M2.21M1.64M2.49M1.70M1.36M3.78M2.97M2.11M2.87M5.41M39.21M53.48M88.44M120.56M145.73M
Total Equity50.00K1.22M1.62M7.62M10.11M3.58M-22.00K-2.92M-469.00K-4.47M-1.69M4.40M7.92M8.23M27.97M25.05M12.02M1.19M6.90M45.59M24.19M2.62M-32.19M-60.24M-103.07M-126.19M
Cash210.00K1.49M1.92M7.61M10.70M4.47M773.00K1.32M318.00K251.00K5.89M6.40M9.36M10.49M29.13M25.85M15.36M3.05M8.25M47.48M27.14M39.65M18.59M25.66M15.12M17.72M
Total Debt80.00K195.00K15.00K---5.14M-200.00K----------39.00K44.00K29.06M39.87M71.81M106.25M133.76M
Net Debt-130.00K-1.30M-1.91M-7.61M-10.70M-4.47M-773.00K-1.32M-118.00K-251.00K-5.89M-6.40M-9.36M-10.49M-29.13M-25.85M-15.36M-3.05M-8.25M-47.44M-27.10M-10.59M21.28M46.15M91.13M116.04M

Cash Flow

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-90.00K-1.80M-2.98M-4.15M-6.33M-6.13M-6.76M-5.48M-4.67M-3.89M-3.10M-5.68M-7.50M-7.48M-12.43M-16.98M-16.41M-15.89M-10.18M-10.85M-20.60M-24.31M-31.06M-32.97M-41.77M-23.88M
Investing Cash Flow-10.00K-171.12K-138.28K-105.70K-69.00K-111.00K-5.24M4.95M9.00K---15.00K64.00K64.00K-400.00K000--------
Financing Cash Flow300.00K3.26M3.55M9.94M9.50M-8.30M1.08M3.65M3.82M8.74M6.20M10.40M8.61M31.46M13.70M5.92M3.58M15.38M50.08M263.00K36.81M10.00M40.03M31.23M26.48M
Capital Expenditure10.00K171.12K123.70K39.36K23.00K21.00K98.00K42.00K2.00K005.00K5.00K5.00K000000000000
Free Cash Flow-100.00K-1.97M-3.09M-4.19M-6.36M-6.15M-6.86M-5.53M-4.67M-3.89M-3.10M-5.68M-7.50M-7.49M-12.43M-16.98M-16.41M-15.89M-10.18M-10.85M-20.60M-24.31M-31.06M-32.97M-41.77M-23.88M
Dividends Paid---------209.00K2.07M1.54M0976.00K943.00K943.00K741.00K1.23M915.00K394.00K137.00K171.00K97.00K120.00K91.00K138.00K
FCF to OCF111.11%109.51%103.66%100.95%100.36%100.34%101.45%100.77%100.04%100.00%100.00%100.09%100.07%100.07%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF----------5.38%-66.83%-27.04%0.00%-13.03%-7.59%-5.55%-4.52%-7.75%-8.99%-3.63%-0.67%-0.70%-0.31%-0.36%-0.22%-0.58%

Earnings

Report DateSep 30, 2002Dec 31, 2002May 14, 2003Aug 14, 2003Nov 14, 2003Mar 30, 2004Apr 29, 2004Aug 5, 2004Nov 10, 2004May 13, 2005Aug 5, 2005Nov 10, 2005Mar 10, 2006May 22, 2006Aug 14, 2006Nov 13, 2006Apr 2, 2007Aug 10, 2007Nov 14, 2007Mar 28, 2008May 15, 2008Aug 8, 2008Nov 7, 2008May 15, 2009Aug 14, 2009Nov 13, 2009Mar 12, 2010May 12, 2010Aug 13, 2010Nov 12, 2010Mar 15, 2011May 13, 2011Aug 12, 2011Nov 10, 2011Mar 30, 2012May 11, 2012Aug 10, 2012Nov 9, 2012Mar 31, 2013May 10, 2013Aug 14, 2013Nov 12, 2013Mar 21, 2014May 13, 2014Aug 7, 2014Nov 10, 2014Mar 18, 2015May 11, 2015Aug 10, 2015Nov 9, 2015Mar 15, 2016May 10, 2016Aug 9, 2016Nov 8, 2016Mar 28, 2017May 15, 2017Aug 14, 2017Nov 7, 2017Mar 29, 2018May 11, 2018Aug 14, 2018Nov 13, 2018Mar 6, 2019May 10, 2019Aug 9, 2019Nov 12, 2019Mar 16, 2020May 11, 2020Aug 10, 2020Nov 9, 2020Mar 31, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 30, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 29, 2024May 15, 2024Aug 13, 2024Nov 14, 2024Mar 27, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Mar 26, 2026May 15, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate-----------------0.60-0.30--0.36----0.14-0.22--0.13---0.09--0.20-0.17-0.25-0.21-0.18-0.14-0.14-0.21-0.17-0.18-0.17-0.17-0.20-0.21-0.27-0.17-0.20-0.23-0.21-0.22-0.19-0.24-0.22-0.17-0.15-0.15-0.15-0.11-0.13-0.11-0.09-0.08-0.14-0.12-0.10-0.06-0.09-0.07-0.14-0.16-0.17-0.18-0.18-0.19-0.14-0.19-0.20-0.17-0.21-0.21-0.16-0.16-0.16-0.16-0.20-0.16-0.11-0.16-0.11-0.10-0.06-0.09-0.05
EPS Actual-0.25-0.41-0.28-0.29-0.37-0.42-0.46-0.33-0.40-0.31-0.37-0.37-0.38-1.61-0.460.101.020.01-0.18-0.12-0.29-0.080.02-0.36-0.42-0.24-0.18-0.34-0.28-0.18-0.16-0.24-0.36-0.18-0.29-0.17-0.19-0.19-0.17-0.22-0.18-0.22-0.15-0.25-0.17-0.17-0.18-0.22-0.21-0.26-0.19-0.24-0.20-0.19-0.12-0.15-0.14-0.13-0.07-0.12-0.11-0.07-0.08-0.20-0.06-0.05-0.12-0.06-0.11-0.10-0.13-0.11-0.15-0.14-0.12-0.17-0.16-0.14-0.18-0.19-0.15-0.24-0.16-0.19-0.20-0.18-0.19-0.15-0.12-0.13-0.08-0.08-0.14-
Surprise----------------270.00%101.80%-66.67%----157.14%-90.91%--38.46%---100.00%--20.00%-111.76%28.00%-38.10%5.56%-35.71%-35.71%19.05%-29.41%0.00%-29.41%11.76%-25.00%19.05%37.04%-5.88%-10.00%8.70%-23.81%13.64%-26.32%16.67%13.64%29.41%0.00%6.67%13.33%36.36%7.69%0.00%22.22%0.00%-42.86%50.00%50.00%-100.00%33.33%-57.14%28.57%18.75%35.29%16.67%22.22%36.84%-21.43%15.79%30.00%-5.88%9.52%28.57%-50.00%0.00%-18.75%-25.00%10.00%-18.75%-36.36%25.00%-18.18%20.00%-33.33%-55.56%-
Timing-----------------Pre-marketPre-marketPre-market-----------Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap393.31M
Enterprise Value545.73M
Trailing P/E0.00
Forward P/E4.54
PEG Ratio0.00
Price / Sales0.00
Price / Book207.70
EPS-0.43
Book Value-2.10
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-3727.95%
Return on Assets-64.18%
Shares Outstanding100.85M
Shares Float47.77M
Beta0.39
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 11.00
  • Strong Buy
    1

Ownership Breakdown

Institutions
15.66%
Insiders
53.08%
Retail / Other
31.26%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    1.97M1.95%
  • Marshall Wace Asset Management Ltd
    1.22M1.21%
  • Advisor Group Holdings, Inc.
    1.12M1.11%
  • BlackRock Inc
    799.24K0.79%
  • Sontag Advisory LLC
    721.79K0.72%
  • Geode Capital Management, LLC
    612.79K0.61%
  • Susquehanna International Group, LLP
    555.70K0.55%
  • Commonwealth Equity Services, LLC
    407.11K0.40%
  • Two Sigma Investments LLC
    318.25K0.32%
  • Vanguard Fiduciary Trust Co
    304.24K0.30%
  • LPL Financial Corp
    267.20K0.26%
  • Vivaldi Capital Management, LLC
    258.58K0.26%
  • State Street Corp
    258.43K0.26%
  • Sovran Advisors, LLC
    257.83K0.26%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.52M1.51%
  • iShares Russell 2000 ETF
    1.05M1.04%
  • Fidelity Small Cap Index
    518.15K0.51%
  • iShares Russell 2000 Growth ETF
    312.25K0.31%
  • Vanguard Russell 2000 ETF
    275.48K0.27%
  • Fidelity Extended Market Index
    265.47K0.26%

Stock Splits

  • Mar 23, 20121:6